Upcoming webinar: A randomised controlled trial of lisdexamfetamine for the treatment of acute methamphetamine withdrawal

This Cracks in the Ice webinar presentation will introduce the Oral Lisdexamphetamine for (OLAM) project, a recently launched multi-site, placebo-controlled RCT evaluating the use of a tapering dose of lisdexamphetamine for methamphetamine

This 1-hour free webinar at 12 pm Sydney time on Tuesday 26th May will also introduce the nested First Nations sub-study, a qualitative study using yarning methodology that will assess the needs and experiences of Aboriginal and Torres Strait Islander participants in the OLAM trial.

Following the presentation, there will be a live Q&A session with questions from webinar attendees. This webinar will be relevant for researchers, people who use methamphetamine, family and community members.

REGISTER TODAY

Presenters: This webinar will be presented by Ms Julie Matheson and Professor Michael Doyle. 

Ms Julie Matheson is an early career First Nations researcher at the University of Sydney. She has experience working in neuroscience, mental health and addictions research.

Professor Michael Doyle is a Bardi man from the Kimberley Region of Western Australia. He has worked in Aboriginal health for over 20 years, commencing his career as an Aboriginal Health Worker at the Broome Regional Aboriginal Medical Service. He is a mixed-methods researcher with a focus on alcohol and other drug (AoD) treatment for Aboriginal men involved in the criminal justice system. 

Page last reviewed: Thursday, 30 April 2026